CME vs INTS
CME Group Inc (CME) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
INTS does not have a complete income-statement cache yet.
CME currently screens at market cap $91.25B and trailing P/E 21.9. INTS currently screens at market cap $7.7M.
Not investment advice. Open the CME and INTS stock pages for the full models.
Not investment advice.